Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.24.3
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2024
NET LOSS PER SHARE  
Schedule of net loss per share, basic and diluted

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands, except per share amounts)

2024

    

2023

    

2024

    

2023

Numerator for basic and diluted net loss per share:

  

 

  

  

 

  

Net loss

$

(35,448)

$

(46,373)

$

(190,986)

$

(148,742)

Denominator for basic and diluted net loss per share:

 

  

 

 

  

 

  

Weighted-average shares

 

33,269

 

32,319

 

33,023

 

32,133

Net loss per share—Basic and Diluted

$

(1.07)

$

(1.43)

$

(5.78)

$

(4.63)

Schedule of antidilutive securities excluded from computation of earnings per share The Company excluded the following potential common shares, presented based on amounts outstanding as of September 30, 2024 and 2023, from the computation of diluted net loss per share attributable to common stockholders because including them would have an anti-dilutive effect (in thousands):

Nine Months Ended September 30, 

2024

    

2023

Common Stock options outstanding

557

6,291

Unvested restricted stock units outstanding

2,699

25,482

Unvested restricted stock awards outstanding

17

6.0% Convertible Senior Notes due 2027

8,646

86,466

Total shares

11,902

118,256